This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Jubilant Pharma Limited
Jubilant Pharma Limited, a prominent player in the pharmaceutical industry, is headquartered in Singapore (SG) and operates extensively across North America, Europe, and Asia. Founded in 2007, the company has rapidly established itself as a leader in contract manufacturing and pharmaceutical services, focusing on areas such as sterile injectables, radiopharmaceuticals, and drug delivery systems. Jubilant Pharma is renowned for its innovative core products, which include a diverse range of high-quality generic and branded pharmaceuticals. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships. With a robust portfolio and a dedication to advancing healthcare solutions, Jubilant Pharma continues to make significant strides in the global pharmaceutical landscape.
DitchCarbon Score
How does Jubilant Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jubilant Pharma Limited's score of 50 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jubilant Pharma Limited, headquartered in Singapore (SG), currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Jubilant Pharmova Limited, which may influence its climate commitments and performance metrics. Despite the absence of direct emissions data, Jubilant Pharma Limited is part of a corporate family that is expected to align with industry standards for climate action. The company has not publicly disclosed any specific reduction targets or initiatives, such as those set by the Science Based Targets initiative (SBTi) or other climate pledges. As a subsidiary, Jubilant Pharma Limited may inherit climate strategies and commitments from its parent company, Jubilant Pharmova Limited. However, details regarding these initiatives or any cascading emissions data from the parent organization are not specified. In summary, while Jubilant Pharma Limited is positioned within a corporate structure that may prioritise climate action, specific emissions data and reduction commitments are currently unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2015 | 2016 | 2017 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 894,456,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 107,906,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 12,057,000 | - | - | - | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jubilant Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
